Cancer Epidemiology, Screening & Prevention

The Epidemiology of Cancer is the study of the factors affecting Cancer, as a way to conclude possible trends and causes. The study of Cancer Epidemiology uses Epidemiological Methods to discover the cause of Cancer and to recognize and develop improved treatments. This area of study must cope with problems of lead time bias and length time bias. Lead time bias is the theory that early diagnosis may artificially inflate the survival statistics of a Cancer, without really improving the natural history of the disease. Length bias is the concept that gentler growing, more lethargic Tumors are more likely to be identified by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs

Prevention or Preventive Healthcare means measures that are taken for Cancer Prevention. Cancer can be prevented by living a healthy lifestyle. A healthy lifestyle and regular screening exams help to reduce your risk for some types of Cancer.

Screenings can find Cancer early, when it’s most treatable. Cancer Screening aims to identify Cancer before symptoms appear. This may involve blood tests, urine tests, other tests, or Medical Imaging. The benefits of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed against any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a specific age group. Selective Screening identifies people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Global trends in Cancer Mortality and Incidence
  • Cancer Epidemiological studies: Principles, Statistics, Methodologies & Reporting
  • Cancer Epidemiological Risk factors
  • Cancer Screening, evaluation and intervention
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Cohort studies and Cancer Survival analysis

Related Conference of Cancer Epidemiology, Screening & Prevention

September 25-26, 2019 |

World Cancer Research and Biomarkers Conference

Toronto, Canada
September 27-28, 2019

Cancer Therapy & Biomarkers

Lisbon, Portugal
October 09-10, 2019

37th World Cancer Conference


Venue: Louis Fitzgerald Hotel
Naas Rd, Newlands Cross
Dublin, D22 X5N7, Ireland
October 23-24, 2019

15th World Congress on Blood Cancer

Prague, Czech Republic
October 23-24, 2019 |

Women Oncology & Nursing Care

Vancouver, British Columbia, Canada
October 24-25, 2019

3rd International Meeting on Womens Health and Breast Cancer

Auckland, Newzealand
November 11-12 2019

3rd Cancer Diagnostics & Treatment Conference

Frankfurt, Germany
November 18-19, 2019

5th World Congress on Cancer and Diagnostics

Osaka, Japan
December 4-5, 2019

Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
December 06-07,2019

11th EURO BREAST CANCER SUMMIT

Prague, Czech Republic
February 10-11, 2020

24th Global Annual Oncologists Meeting

Auckland, New Zealand
February 25-26, 2020

4th Global Summit on Cancer

| Tokyo, Japan
March 09-10, 2020

40th Euro Congress on Cancer Science & Therapy

Rome, Italy
March 30-31 | 2020

20th Global Cancer Summit

| Kyoto, Japan
April 14-15, 2020

World Congress on Women Oncology & Care

Tokyo , Japan
June 15-16, 2020

5th World Congress on Cancer and Diagnostics

Berlin, Germany
June 22-23, 2020

18th Asia Pacific
Oncologists Annual Meeting

Brisbane, Australia
July 09-10, 2020

5th International Conference on Preventive Oncology

Berlin, Germany
July 13-14, 2020

31st Cancer Research and Therapy Summit

| Brisbane, Australia

Cancer Epidemiology, Screening & Prevention Conference Speakers

Recommended Sessions

Related Journals

Are you interested in